Trial intelligence / Profile preview

Qianlie Huikang tablets in nonbacterial chronic prostatitis

CTR20132053Phase 2Suspended

Sponsor
Tonghua Tianli Pharmaceutical
Start
Jan 2014
Countries
1
01

Overview

A Phase 2 trial of qianlie huikang in chronic prostatitis (CP), sponsored by Tonghua Tianli Pharmaceutical. Started Jan 2014; status: suspended.

02

Drugs

qianlie huikang
03

Conditions

chronic prostatitis (CP)

Beyond the preview

Go deeper on CTR20132053.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20132053.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call